Aquisição do medicamento Brexucabtagene autoleucel
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Apr 5,Expired
- Award
- Price only
- Agreement
- Buying goods
Brief
O Instituto Português de Oncologia do Porto Francisco Gentil, EPE celebrou um contrato com a Gilead Sciences, Lda para a aquisição do medicamento Brexucabtagene autoleucel, no valor de 1.632.504 €.
Farmasøytisk engroshandel
Result
- GILEAD SCIENCES, LDAWinner
- 1Number of bids
- €1,632,504Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Preço
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Instituto Português de Oncologia do Porto Francisco Gentil, EPE
From the notice
Aquisição do medicamento Brexucabtagene autoleucel
Contact
compras@ipoporto.min-saude.pt- ResultType
- 33600000Main codePharmaceutical products